[go: up one dir, main page]

WO2006124888A3 - Detection of antigen specific immunocomplexes - Google Patents

Detection of antigen specific immunocomplexes Download PDF

Info

Publication number
WO2006124888A3
WO2006124888A3 PCT/US2006/018902 US2006018902W WO2006124888A3 WO 2006124888 A3 WO2006124888 A3 WO 2006124888A3 US 2006018902 W US2006018902 W US 2006018902W WO 2006124888 A3 WO2006124888 A3 WO 2006124888A3
Authority
WO
WIPO (PCT)
Prior art keywords
detection
antigen specific
specific immunocomplexes
immunocomplexes
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/018902
Other languages
French (fr)
Other versions
WO2006124888A2 (en
Inventor
Daniel C Dantini
Brent Dorval
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brendan BioScience LLC
Original Assignee
Brendan BioScience LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brendan BioScience LLC filed Critical Brendan BioScience LLC
Publication of WO2006124888A2 publication Critical patent/WO2006124888A2/en
Publication of WO2006124888A3 publication Critical patent/WO2006124888A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to methods and devices for detecting biological entities and components associated with hypersensitivity reactions in patients with allergies, cancer or autoimmune disease. Specifically, the assays of the invention are capable of qualitatively and/or quantitatively detecting allergen specific immunocomplexes by assaying for immobilized C3b in a biological sample produced as a result of exposure to food.
PCT/US2006/018902 2005-05-16 2006-05-16 Detection of antigen specific immunocomplexes Ceased WO2006124888A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68115405P 2005-05-16 2005-05-16
US60/681,154 2005-05-16

Publications (2)

Publication Number Publication Date
WO2006124888A2 WO2006124888A2 (en) 2006-11-23
WO2006124888A3 true WO2006124888A3 (en) 2007-05-24

Family

ID=37432032

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/018902 Ceased WO2006124888A2 (en) 2005-05-16 2006-05-16 Detection of antigen specific immunocomplexes

Country Status (1)

Country Link
WO (1) WO2006124888A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3095876A1 (en) * 2010-11-02 2016-11-23 Kypha, Inc. Point of care lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders
US8865164B2 (en) 2010-11-02 2014-10-21 Kypha, Inc. Detecting complement activation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960712A (en) * 1983-11-15 1990-10-02 Scripps Clinic And Research Foundation System and method for complement pathway analysis
WO2005078442A1 (en) * 2004-02-10 2005-08-25 Dantini Daniel C Comprehensive food allergy test

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960712A (en) * 1983-11-15 1990-10-02 Scripps Clinic And Research Foundation System and method for complement pathway analysis
WO2005078442A1 (en) * 2004-02-10 2005-08-25 Dantini Daniel C Comprehensive food allergy test

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BUNNAG C ET AL: "A PRELIMINARY STUDY OF CIRCULATING IMMUNE COMPLEXES DURING ALLERGEN IMMUNOTHERAPY IN THAI PATIENTS", ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, vol. 7, no. 1, 1989, pages 15 - 22, XP009080768, ISSN: 0125-877X *
IIDA K ET AL: "A SOLID-PHASE ANTI-C3 ASSAY FOR DETECTION OF IMMUNE COMPLEXES IN SIX DISTINGUISHED FORMS", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 98, no. 1, 1987, pages 23 - 28, XP002332792, ISSN: 0022-1759 *

Also Published As

Publication number Publication date
WO2006124888A2 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
GB0319376D0 (en) Histone modification detection
WO2008060394A3 (en) Methods and assays for detecting gp73-specific autoantibodies
WO2007003344A3 (en) Device for quantitative analysis of a metabolite profile
WO2008051762A3 (en) Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
WO2006137824A3 (en) Methods and systems for detecting biomolecular binding using terahertz radiation
JP2010504530A5 (en)
WO2006108087A3 (en) Devices and methods for enrichment and alteration of circulating tumor cells and other particles
WO2002061129A3 (en) Oligonucleotide identifiers
WO2015070037A3 (en) Polynucleotide conjugates and methods for analyte detection
WO2009121032A3 (en) Sample preparation devices and methods for processing analytes
WO2006047670A3 (en) Methods for assessing antibodies to neurodegenerative disease-associated antigens
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
WO2008106648A3 (en) Immunoassays exhibiting a reduction in prozone phenomena
EP2194380A3 (en) Detection of a target antigen irrespective of the presence or absence of a corresponding therapeutic antibody
NZ609824A (en) Immunochromatography devices, methods and kits
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
WO2008048508A3 (en) Prognostic biomarkers in patients with ovarian cancer
GB2404022B (en) Competitive assays for the detection of methamphetamine group drugs
WO2007030531A3 (en) Reagents for testing and molecular imaging of liver cancer
WO2008124091A3 (en) Compositions and methods of detection
WO2009058331A3 (en) Biomarkers for the detection of early stage ovarian cancer
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
WO2007079229A3 (en) Devices and methods for enrichment and alteration of circulating tumor cells and other particles
WO2008131261A3 (en) Peptide biomarkers of cardiovascular disease

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06770429

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06770429

Country of ref document: EP

Kind code of ref document: A2